文献速递产科母胎医学

胎盘功能障碍与子痫前期中分娩前母体循环中性粒细胞胞外诱捕网及脱氧核糖核酸酶水平

Predelivery maternal circulating neutrophil extracellular traps and deoxyribonuclease in placental dysfunction and preeclampsia.
PubMed 文献 · Am J Obstet Gynecol · 2025-10-15

本研究检测早发型子痫前期(n=49)、晚发型子痫前期(n=202)、妊娠期高血压(n=105)、孤立性胎儿生长受限(n=50)及血压正常血糖正常对照(n=1126)孕妇循环中性粒细胞胞外诱捕网标志物与脱氧核糖核酸酶水平。结果显示早发型和晚发型子痫前期孕妇循环瓜氨酸化组蛋白H3和脱氧核糖核酸酶中位水平低于对照(均校正P<.001),晚发型子痫前期髓过氧化物酶-DNA也低于对照(校正P<.001);妊娠期高血压和孤立性胎儿生长受限无此差异。

要点

  • 早发型和晚发型子痫前期孕妇循环瓜氨酸化组蛋白H3和脱氧核糖核酸酶中位水平低于对照(均校正P<.001)。
  • 晚发型子痫前期孕妇髓过氧化物酶-DNA低于对照(校正P<.001),妊娠期高血压和孤立性胎儿生长受限无显著差异。
  • 子痫前期组中瓜氨酸化组蛋白H3与胎盘生长因子正相关(P=.004),与可溶性fms样酪氨酸激酶-1负相关(P=.034)。

核心结论

  • 子痫前期孕妇循环中性粒细胞胞外诱捕网和脱氧核糖核酸酶水平降低,而妊娠期高血压和孤立性胎儿生长受限无此改变,提示中性粒细胞胞外诱捕网可能参与子痫前期特有的胎盘功能障碍。
  • 低瓜氨酸化组蛋白H3、低脱氧核糖核酸酶与母体高血压的关联可能提示循环脱氧核糖核酸酶不足参与子痫前期孕妇的过度血管炎症。

研究设计与样本

  • 研究纳入早发型子痫前期(n=49)、晚发型子痫前期(n=202)、妊娠期高血压(n=105)、孤立性胎儿生长受限(n=50)及血压正常血糖正常对照(n=1126)孕妇,采用免疫分析法检测血浆和血清中性粒细胞胞外诱捕网标志物(瓜氨酸化组蛋白H3、髓过氧化物酶-DNA)、脱氧核糖核酸酶及胎盘功能障碍标志物(可溶性fms样酪氨酸激酶-1、胎盘生长因子)。
  • 组间比较采用Kruskal-Wallis H检验,事后两两比较采用Dunn检验并以Bonferroni校正多重比较;在子痫前期孕妇中采用单变量和多变量分位数(中位数)回归分析标志物与胎盘功能障碍替代指标的关联,双侧P<.05为统计学显著。

主要发现

  • 早发型和晚发型子痫前期孕妇循环瓜氨酸化组蛋白H3中位水平低于对照(均校正P<.001),脱氧核糖核酸酶中位水平也低于对照(均校正P<.001)。
  • 晚发型子痫前期孕妇髓过氧化物酶-DNA低于对照(校正P<.001);妊娠期高血压和孤立性胎儿生长受限孕妇未见上述标志物与对照的显著差异。
  • 子痫前期组单变量回归显示瓜氨酸化组蛋白H3与胎盘生长因子正相关(P=.004),瓜氨酸化组蛋白H3与可溶性fms样酪氨酸激酶-1负相关(P=.034),脱氧核糖核酸酶与可溶性fms样酪氨酸激酶-1负相关(P=.038)。
  • 多变量回归显示瓜氨酸化组蛋白H3与胎盘生长因子正相关(P=.009),脱氧核糖核酸酶与采血时孕周正相关(P=.001),瓜氨酸化组蛋白H3(P=.027)和脱氧核糖核酸酶(P=.034)与收缩压负相关。
  • 瓜氨酸化组蛋白H3与新生儿体重≤第10百分位(胎儿胎盘功能障碍替代指标)相关(P=.036)。

临床怎么用

  • 原文结论指出,循环中性粒细胞胞外诱捕网和脱氧核糖核酸酶降低及瓜氨酸化组蛋白H3与胎盘功能障碍标志物的关联可能提示中性粒细胞胞外诱捕网参与子痫前期特有的胎盘功能障碍;低瓜氨酸化组蛋白H3、低脱氧核糖核酸酶与高母体血压的关联可能提示循环脱氧核糖核酸酶不足参与子痫前期的过度血管炎症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neutrophil extracellular traps consist of DNA and protein and are secreted by neutrophils upon activation. They are stable structures but may be degraded by deoxyribonucleases. Neutrophil extracellular traps can induce endothelial dysfunction, an important feature of the preeclampsia pathophysiology. However, the levels of neutrophil extracellular traps biomarkers and deoxyribonuclease in the maternal circulation during preeclampsia, gestational hypertension, and fetal growth restriction, as well as potential associations to placental dysfunction, remain to be elucidated. OBJECTIVE: We aimed to investigate levels of circulating neutrophil extracellular traps biomarkers and deoxyribonuclease in women with early-onset and late-onset preeclampsia, gestational hypertension, and isolated fetal growth restriction compared to clinically healthy pregnancies. Additionally, we aimed to compare these biomarkers with circulating placental dysfunction biomarkers and maternal as well as fetal clinical proxies of placental dysfunction in women with preeclampsia. STUDY DESIGN: Plasma and serum samples from women categorized as having early-onset preeclampsia (n=49), late-onset preeclampsia (n=202), gestational hypertension (n=105), isolated fetal growth restriction (n=50), and normotensive, euglycemic controls (n=1126) were analyzed by immunoassays for the circulating neutrophil extracellular traps biomarkers citrullinated histone H3 and myeloperoxidase-DNA and deoxyribonuclease and for the placental dysfunction biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor. The Kruskal-Wallis H test was used to compare biomarker levels across groups. Post hoc pairwise comparisons were conducted using Dunn's test, with Bonferroni correction applied to adjust for multiple comparisons. In women with early-onset and late-onset preeclampsia, the residuals were not normally distributed. Therefore, univariable and multivariable quantile (median) regression for estimating models for the conditional median function were used to study associations between our biomarkers of interest and proxies for placental dysfunction. A 2-sided P value of <.05 was considered statistically significant. RESULTS: Women with early-onset and late-onset preeclampsia, but not gestational hypertension or isolated fetal growth restriction, had lower median levels of circulating citrullinated histone H3 (both adjusted P<.001) and deoxyribonuclease (both adjusted P<.001) compared to controls. Women with late-onset preeclampsia had lower myeloperoxidase-DNA (adjusted P<.001) compared to controls. Univariable regression analyses within the preeclampsia group revealed positive associations between citrullinated histone H3 and placental growth factor (P=.004) and negative associations between citrullinated histone H3 and soluble fms-like tyrosine kinase-1 (P=.034) and between deoxyribonuclease and soluble fms-like tyrosine kinase-1 (P=.038). In multivariable regression analyses, citrullinated histone H3 and placental growth factor (P=.009) and deoxyribonuclease and gestational age at blood sampling (P=.001) were positively associated, whereas citrullinated histone H3 (P=.027) and deoxyribonuclease (P=.034) were negatively associated with systolic blood pressure. Finally, citrullinated histone H3 was associated with newborn weight ≤10th percentile, representing a fetal proxy for placental dysfunction (P=.036). CONCLUSION: The lower levels of circulating neutrophil extracellular traps and deoxyribonuclease in women with preeclampsia, but not in gestational hypertension or isolated fetal growth restriction, as well as associations between citrullinated histone H3 and biomarkers of placental dysfunction may indicate that neutrophil extracellular traps play a role in the placental dysfunction that exclusively characterizes preeclampsia. Additionally, the association between low citrullinated histone H3, low deoxyribonuclease, and high maternal blood pressure may suggest that insufficient presence of circulating deoxyribonucleases contributes to the excessive vascular inflammation in women with preeclampsia.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sundet BK, Sugulle M, Jacobsen DP, et al. Predelivery maternal circulating neutrophil extracellular traps and deoxyribonuclease in placental dysfunction and preeclampsia. Am J Obstet Gynecol. 2025. PMID: 41106578. doi:10.1016/j.ajog.2025.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。